Lipid nanoparticles have emerged as promising carriers for drug delivery due to their biocompatibility, versatility, and ability to encapsulate a wide range of therapeutic agents. This review article explores the recent advancements in lipid nanoparticles and their applications in pharmaceutical formulations. The article discusses various types of lipid nanoparticles, including solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), and lipid-drug conjugates, highlighting their unique characteristics and advantages. The focus is on their potential to overcome challenges associated with traditional drug delivery systems, such as poor bioavailability, limited stability, and off-target effects
Despite the development of novel drugs and technologies in combating the infectious diseases, they r...
ABSTRACT The solid lipid nanoparticles possess a lipid core matrix in a nanometer range, stabilized...
More than half of all people diagnosed with cancer receive chemotherapy. Unfortunately, most chemoth...
During the past decade, the number of studies describing nanostructured lipid carriers (NLC)-based f...
ABSTRACT Colloidal particles of size range between 10 and 1000 nm are known as nanoparticles. Over ...
During the past decade, the number of studies describing nanostructured lipid carriers (NLCs)-based ...
Solid lipid nanoparticles (SLNs) gained greater attention as a drug delivery system when in 1991 M€u...
Solid lipid nanoparticles (SLNs) gained greater attention as a drug delivery system when in 1991 M€u...
The solid lipid nanoparticles (SLNs), a type of lipid nanoparticles (LNPs), is a special field of in...
Solid lipid nanoparticles (SLNs) are nanocarriers developed as substitute colloidal drug delivery sy...
To date, numerous nano-drug systems for different routes of administration have been evolved, includ...
Solid lipid nanoparticles (SLN) are the heart of nanotechnology's tremendous development, with multi...
Solid lipid nanoparticles (SLNs) are produced from physiologically biocompatible lipids. They have b...
The era of nanotechnology has revolutionized the drug delivery system and persuades new research str...
Solid lipid nanoparticles, which have numerous powerful advantages for clinical therapy, drug transp...
Despite the development of novel drugs and technologies in combating the infectious diseases, they r...
ABSTRACT The solid lipid nanoparticles possess a lipid core matrix in a nanometer range, stabilized...
More than half of all people diagnosed with cancer receive chemotherapy. Unfortunately, most chemoth...
During the past decade, the number of studies describing nanostructured lipid carriers (NLC)-based f...
ABSTRACT Colloidal particles of size range between 10 and 1000 nm are known as nanoparticles. Over ...
During the past decade, the number of studies describing nanostructured lipid carriers (NLCs)-based ...
Solid lipid nanoparticles (SLNs) gained greater attention as a drug delivery system when in 1991 M€u...
Solid lipid nanoparticles (SLNs) gained greater attention as a drug delivery system when in 1991 M€u...
The solid lipid nanoparticles (SLNs), a type of lipid nanoparticles (LNPs), is a special field of in...
Solid lipid nanoparticles (SLNs) are nanocarriers developed as substitute colloidal drug delivery sy...
To date, numerous nano-drug systems for different routes of administration have been evolved, includ...
Solid lipid nanoparticles (SLN) are the heart of nanotechnology's tremendous development, with multi...
Solid lipid nanoparticles (SLNs) are produced from physiologically biocompatible lipids. They have b...
The era of nanotechnology has revolutionized the drug delivery system and persuades new research str...
Solid lipid nanoparticles, which have numerous powerful advantages for clinical therapy, drug transp...
Despite the development of novel drugs and technologies in combating the infectious diseases, they r...
ABSTRACT The solid lipid nanoparticles possess a lipid core matrix in a nanometer range, stabilized...
More than half of all people diagnosed with cancer receive chemotherapy. Unfortunately, most chemoth...